Gene-modified, donor cell therapy – Page 7

Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

Post author:
Post published:July 15, 2026
Post category:

Critical limb ischemia (CLI) represents a significant unmet medical need without any approved medical therapies for patients who fail surgical or angioplasty procedures to restore blood flow to the lower…

MSC engineered to produce BDNF for the treatment of Huntington’s disease

Post author:
Post published:July 15, 2026
Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Human ES cell based therapy of heart failure without allogenic immune rejection

Post author:
Post published:July 15, 2026
Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…